Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Tirzepatide

SURMOUNT-1

Eli Lilly · Phase 3 · Recruiting · Enrollment 2539

NCT07481747

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Arm 1: Tirzepatide 5 mg once weekly + lifestyle interventionn/rn/rn/rn/rn/r
Arm 2: Tirzepatide 10 mg once weekly + lifestyle interventionn/rn/rn/rn/rn/r
Arm 3: Tirzepatide 15 mg once weekly + lifestyle interventionn/rn/rn/rn/rn/r
Arm 4: Placebo once weekly + lifestyle interventionn/rn/rn/rn/rn/r

A count stays a count. This page does not turn a count into a percent.